Abstract:
Devices, systems, and methods are described herein for controlling the level of one or more target cell types in the blood fluid and/or lymph fluid of a vertebrate subject. Devices and systems are provided that include a body defining at least one lumen configured for fluid flow; at least one controllable flow barrier to the at least one lumen; one or more sensor configured to detect one or more target cell types in blood fluid or lymph fluid of a vertebrate subject; at least one treatment region disposed within the at least one lumen; at least one reactive component disposed in the at least one treatment region; and at least one controller in communication with the one or more sensor and in communication with the at least one controllable flow barrier to the at least one lumen.
Abstract:
Devices, systems, and methods are described herein for controlling the level of one or more target cell types in the blood fluid and/or lymph fluid of a vertebrate subject. Devices, systems, and methods are provided that include a body defining at least one lumen configured for fluid flow; at least one controllable flow barrier to the at least one lumen; one or more sensor configured to detect one or more target cell types in blood fluid or lymph fluid of a vertebrate subject; at least one treatment region disposed within the at least one lumen; at least one reactive component disposed in the at least one treatment region; and at least one controller in communication with the one or more sensor and in communication with the at least one controllable flow barrier to the at least one lumen.
Abstract:
Devices, systems, and methods are described herein for controlling the level of one or more target cell types in the blood fluid and/or lymph fluid of a vertebrate subject. Devices, systems, and methods are provided that include a body defining at least one lumen configured for fluid flow; at least one controllable flow barrier to the at least one lumen; one or more sensor configured to detect one or more target cell types in blood fluid or lymph fluid of a vertebrate subject; at least one treatment region disposed within the at least one lumen; at least one reactive component disposed in the at least one treatment region; and at least one controller in communication with the one or more sensor and in communication with the at least one controllable flow barrier to the at least one lumen.
Abstract:
Systems, devices, methods, and compositions are described for providing real-time monitoring of cerebrospinal fluid for markers of progressive conditions.
Abstract:
A computationally implemented method includes, but is not limited to: determining whether a plurality of end users deviated from compliantly executing a template designed to facilitate the plurality of end users in achieving one or more target outcomes when one or more emulatable aspects included in the template are emulated by the plurality of end users, the one or more emulatable aspects being based on one or more relevant reported aspects of one or more source users that were deemed to have been relevant to achieving the one or more target outcomes; and modifying the template based, at least in part, on determining that the plurality of end users deviated from compliantly executing the template In addition to the foregoing, other method aspects are described in the claims, drawings, and text forming a part of the present disclosure.
Abstract:
A computationally implemented method includes, but is not limited to: detecting deviation from a compliant execution of a template by an end user, the template designed to facilitate the end user to achieve one or more target outcomes when one or more emulatable aspects included in the template are emulated, the one or more emulatable aspects being based on one or more relevant reported aspects of one or more source users that are relevant to achieving the one or more target outcomes; and executing one or more actions in response to the detecting of the deviation In addition to the foregoing, other method aspects are described in the claims, drawings, and text forming a part of the present disclosure.
Abstract:
A computationally implemented method includes, but is not limited to: receiving a request for a personalized plan designed to facilitate an end user to achieve one or more target outcomes when one or more emulatable aspects indicated by the personalized plan are emulated, the request identifying at least a source user; acquiring source user data indicating a plurality of reported aspects associated with at least the source user in response to receiving the request; and developing the personalized plan by at least determining which of the plurality of reported aspects associated with the source user are relevant to the achievement of the one or more target outcomes. In addition to the foregoing, other method aspects are described in the claims, drawings, and text forming a part of the present disclosure.
Abstract:
A computationally implemented method includes, but is not limited to: receiving one or more requests indicating at least one or more target outcomes of one or more particular templates, the one or more particular templates designed to facilitate one or more end users to achieve the one or more target outcomes when one or more emulatable aspects included in the one or more particular templates are emulated; and providing from a plurality of templates the one or more particular templates, the providing being based at least on the one or more particular templates' association with the one or more target outcomes, the one or more particular templates developed based on one or more reported aspects of one or more source users In addition to the foregoing, other method aspects are described in the claims, drawings, and text forming a part of the present disclosure.
Abstract:
Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at low temperatures. In certain embodiments, the frozen particles provide vehicles for delivery of particular agents. In certain embodiments, the frozen particles are administered to at least one substrate.
Abstract:
A computationally implemented method includes, but is not limited to: identifying one or more relevant reported aspects associated with one or more source users that are relevant to achieving one or more target outcomes, the identifying of the one or more relevant reported aspects being based, at least in part, on the one or more relevant reported aspects' relevancy with respect to the one or more target outcomes; and developing one or more personalized plans designed to facilitate an end user to achieve the one or more target outcomes when one or more emulatable aspects indicated by the one or more personalized plans are emulated, the development of the one or more personalized plans being based, at least in part, on the identifying. In addition to the foregoing, other method aspects are described in the claims, drawings, and text forming a part of the present disclosure.